Article
Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AβPP(Swe)PSEN1(ΔE9) mice.
Journal of Alzheimer's disease : JAD - 1 Jan 2012
Bengtsson Sara K, Johansson Maja, Bäckström Torbjörn, Wang Mingde
Abstract excerpt
The endogenous neurosteroid allopregnanolone alters neuronal excitability via modulation of the GABAA receptor and causes decreased neurotransmission. In Alzheimer's disease (AD), neurotransmission seems to alter the levels of toxic intracellular amyloid-β (Aβ) oligomers, which are implicated in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
